These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7349434)

  • 1. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E; Paris R
    Reprod Nutr Dev (1980); 1980; 20(3A):637-45. PubMed ID: 7349434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clofibrate on the metabolism of oleate in the perfused rat liver.
    Ide T; Sugano M
    Biochem Pharmacol; 1983 Sep; 32(17):2583-8. PubMed ID: 6615553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of lipid normalizers (clofibrate and procetofene) on chylomicron metabolism in rats].
    Bourdeaux AM; Paris RM
    Arch Int Physiol Biochim; 1980 Feb; 88(1):75-84. PubMed ID: 6155886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.
    Litherland NB; Bionaz M; Wallace RL; Loor JJ; Drackley JK
    J Dairy Sci; 2010 Jun; 93(6):2404-18. PubMed ID: 20494149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of procetofen on lipid metabolism in normocholesteremic rats.
    Kritchevsky D; Tepper SA; Story JA
    Pharmacol Res Commun; 1979 Sep; 11(8):635-41. PubMed ID: 515111
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo.
    Elam MB; Simkevich CP; Solomon SS; Wilcox HG; Heimberg M
    Endocrinology; 1988 Apr; 122(4):1397-402. PubMed ID: 3345719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate.
    Yamamoto K; Fukuda N; Zhang L; Sakai T
    Pharmacol Res; 1996 Jun; 33(6):337-42. PubMed ID: 8971955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal responses to clofibrate in ketogenesis and triglyceride and cholesterol secretion in isolated rat liver.
    Ide T; Oku H; Sugano M
    Metabolism; 1982 Oct; 31(10):1065-72. PubMed ID: 7132732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of fatty acid utilization by sodium clofibrate in rat and monkey hepatocytes.
    Capuzzi DM; Intenzo CM; Lackman RD; Whereat AF; Scott DM
    Biochem Pharmacol; 1983 Jul; 32(14):2195-203. PubMed ID: 6409117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment.
    Mannaerts GP; Thomas J; Debeer LJ; McGarry JD; Foster DW
    Biochim Biophys Acta; 1978 May; 529(2):201-11. PubMed ID: 656451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver.
    Ockner RK; Burnett DA; Lysenko N; Manning JA
    J Clin Invest; 1979 Jul; 64(1):172-81. PubMed ID: 447853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of fenofibrate (author's transl)].
    Kritchevsky D
    Nouv Presse Med; 1980 Dec; 9(49):3769-73. PubMed ID: 7208345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of aldehyde dehydrogenase activity in rat liver by clofibrate feeding.
    Kramar R; Kremser K
    Enzyme; 1984; 31(1):17-20. PubMed ID: 6714196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats.
    Yagasaki K; Okada K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1984 Oct; 33(20):3151-63. PubMed ID: 6548383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic triglyceride formation by clofibrate.
    Adams LL; Webb WW; Fallon HJ
    J Clin Invest; 1971 Nov; 50(11):2339-46. PubMed ID: 5096518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of energy balance on hepatic capacity for oleate and propionate metabolism and triglyceride secretion.
    Armentano LE; Grummer RR; Bertics SJ; Skaar TC; Donkin SS
    J Dairy Sci; 1991 Jan; 74(1):132-9. PubMed ID: 2030168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid.
    Nakagawa M; Ishihara N; Shimokawa T; Kojima S
    J Biochem; 1987 Jan; 101(1):81-8. PubMed ID: 3571211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
    Brass EP; Ruff LJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1034-8. PubMed ID: 2046019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.